據安迅思倫敦5月31日消息,朗盛公司和Advent公司周二表示,兩家公司將收購荷蘭專用化學品公司帝斯曼旗下工程材料部門,并打算將該部門與朗盛自己的高性能材料業務合并。
在帝斯曼宣布計劃與總部位于瑞士的香精香料公司Firmenich合并數小時后,這家荷蘭公司同意出售其工程材料業務,標志著該公司最終轉型為一家健康、營養和生物科學專業公司。
Advent將支付約37億歐元收購帝斯曼工程材料業務。帝斯曼工程材料業務將與朗盛公司旗下高性能材料業務合并成立一家合資公司,總部位于美國的私人股本公司Advent將成為合資公司的控股股東。
兩家公司表示,Advent將向朗盛額外支付11億歐元,朗盛公司將在合資公司中持有約40%的股份。
這筆交易預計將于2023年上半年完成,合并后的帝斯曼/朗盛業務預計將實現約30億歐元的年銷售額。
龐曉華 摘譯自 ICIS
原文如下:
LANXESS, Advent to acquire DSM engineering materials arm, establish joint
LANXESS and Advent are to acquire the engineering materials division of Netherlands-based specialties player DSM, the companies said on Tuesday, with an eye to merging the operations with LANXESS’ own high-performance materials business.
Coming hours after an announcement by DSM of plans to merge with Switzerland-based flavours and fragrances player Firmenich, the Dutch company agreed to sell its engineering materials business, signalling its final transformation into a health, nutrition, and biosciences specialist.
Advent is to pay around 3.7bn for the DSM business, which is to be folded into a joint venture with LANXESS high-performance materials business, with the US-headquartered private equity firm to stand as the majority owner of the combined operations.
Advent is to pay out an additional 1.1bn to LANXESS, with the Germany-based chemicals business to hold a stake of around 40% in the joint venture, the companies said.
The deal is expected to close in the first half of 2023, with the combined DSM/LANXESS business expected to have combined annual sales of around 3bn.
免責聲明:本網轉載自其它媒體的文章及圖片,目的在于弘揚石化精神,傳遞更多石化信息,宣傳國家石化產業政策,展示國家石化產業形象,參與國際石化產業輿論競爭,提高國際石化產業話語權,并不代表本網贊同其觀點和對其真實性負責,在此我們謹向原作者和原媒體致以崇高敬意。如果您認為本站文章及圖片侵犯了您的版權,請與我們聯系,我們將第一時間刪除。